|
Categories
Pharmaceutical Company
Pharmaceutical Sales
Pharmaceutical
Distributor
Pharmaceutical
Preparation
Pharmaceutical
Jobs
Pharmaceutical
Industry
Pharmaceutical
Drug
Pharmaceutical
Sales Jobs
Pharmaceutical
Product
Pharmaceutical
News
Pharmaceutical
Research
Pharmaceutical
Manufacturer
Pharmaceutical Sales
Rep
Pharmaceutical
Sales Resume
Pharmaceutical
Online
Pharmaceutical
Marketing
Pharmaceutical
Dictionary
Pharmaceutical
Recruiter
Pharmaceutical
Supply
Pharmaceutical
Technology
Pharmaceutical
Advertising
Pharmaceutical
Schools
Companies
Pfizer Pharmaceutical
Wyeth Pharmaceutical
Watson Pharmaceutical
Merck Pharmaceutical
Roche Pharmaceutical
King Pharmaceutical
Teva Pharmaceutical
Aventis
Pharmaceutical
Novartis
Pharmaceutical
Forest
Pharmaceutical
Tap
Pharmaceutical
Shire
Pharmaceutical
Mayne
Pharmaceutical
Millennium
Pharmaceutical
Lilly
Pharmaceutical
Mylan
Pharmaceutical
Kos
Pharmaceutical
Takeda
Pharmaceutical
Endo
Pharmaceutical
Janssen
Pharmaceutical
Barr
Pharmaceutical
Abbott
Pharmaceutical
Reliant
Pharmaceutical
Solvay
Pharmaceutical
Amylin
Pharmaceutical
Vertex
Pharmaceutical
Osi
Pharmaceutical
Bayer
Pharmaceutical
Voyager
Pharmaceutical
Mcneil
Pharmaceutical
Boehringer
Ingelheim
Astra
Zeneca Pharmaceutical
Glaxosmithkline
Pharmaceutical
Novo Nordisk
Pharmaceutical
3m
Pharmaceutical
Eli
Lilly Pharmaceutical
Elan Pharmaceutical
Ivax
Pharmaceutical
Search engines:
Google
Lycos
AltaVista
Yahoo
Mirago
Ask
Teoma
Excite |
|
|
|
Mylan Pharmaceutical
Mylan Pharmaceutical
Mylan
Laboratories Inc. is one of the world's leading manufacturers of prescription
medicines specializing in developing, manufacturing and marketing generic
pharmaceuticals. Mylan manufactures and markets 160 generic products in nearly
400 product strengths, covering 46 therapeutic categories. During the most
recent fiscal year, Mylan shipped more than 12.6 billion dosages, and more than
230 million prescriptions were dispensed in the United States with Mylan
products.
Mylan manufactures products for conditions ranging from
angina to arthritis, depression to diabetes, pain to Parkinson's disease, and
schizophrenia to sleep disorders, to name just a few. Mylan has a
well-established reputation for quality, and is a leader in the development and
production of sophisticated dosage forms such transdermal patches, as well as
extended-release tablets and capsules.
Mylan is proud to have been a
driving force in the formation and phenomenal growth of the generic
pharmaceutical industry. Since 1984, generic utilization has increased from
approximately 19% of prescriptions dispensed to over 50% of prescriptions
dispensed in the United States today. Generics have become an absolutely
critical component of the health care system as they save consumers, insurers
and other prescription drug buyers billions of dollars every year. These
savings have made maintaining programs such as Medicaid and private drug
benefit plans possible.
Mylan is headquartered just outside of
Pittsburgh. The company operates through its three subsidiaries: Mylan
Pharmaceuticals (Morgantown, W.Va.) is primarily focused on solid oral dose
generic pharmaceutical products. Mylan Technologies (St. Albans, Vt.) is the
market leader in generic transdermal drug delivery technology and is the
largest producer of generic transdermal patches for the U.S. market. UDL
Laboratories (Rockford, Ill.) is the number one supplier of unit dose
pharmaceuticals to hospitals and other institutions across the United
States.
Significant opportunities lie ahead for Mylan. There is expected
to be a significant number of branded products coming off patent industry-wide
over the next several years, with more than $75 billion of branded
pharmaceuticals potentially losing exclusivity between 2005 and 2008. Mylan has
made significant investments in R&D over the past several years and now has
the deepest product pipeline in the history of the company, including generic
drug submissions pending before the FDA that represent more than $35 billion of
2004 branded pharmaceutical sales. Mylan anticipates obtaining approval of over
100 new products over the next five years.
Mylan Laboratories
Products
Mylan Pharmaceuticals Inc. is a market leader in
developing, manufacturing and marketing generic pharmaceutical products in a
variety of dosage forms. Mylan has a long-standing reputation for quality and
integrity and maintains its commitment to increasing and protecting consumer
access to affordable pharmaceuticals.
www.mylanpharms.com/
Mylan
Technologies Inc. is an innovator and market leader in transdermal drug
delivery technology. Mylan Technologies is a fully integrated resource with
design, development and manufacturing capabilities and has developed and
marketed more generic transdermal products than any company in the United
States.
www.mylantech.com/
UDL Laboratories
Inc. is a market leader in pharmaceutical unit dose packaging for hospitals,
nursing homes and other healthcare institutions. UDL holds a prominent position
in generic and overall unit dose supply with the largest unit dose product line
in the United States. UDL's innovations have contributed to a reduction in
dispensing errors, increases efficiency and significantly improved patient care
at thousands of hospitals and institutions around the country.
www.udllabs.com/ |
|
|
|
|
